Submitted by Anonymous (not verified) on 21 April 2026 - 13:30
Human medicines European public assessment report (EPAR): Evrysdi, risdiplam, Date of authorisation: 26/03/2021, Revision: 16, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Evrysdi, risdiplam, Date of authorisation: 26/03/2021, Revision: 16, Status: Authorised